drugs

See the following -

"More Marketing Than Science" - An Anonymous Confession About Deceptive Marketing Published in the British Medical Journal

Roy M. Poses | Health Care Renewal | June 26, 2012

The British Medical Journal just published an anonymous article by a pharmaceutical company insider that explained once again how pharmaceutical companies turn research studies, apparently scholarly articles, and medical education into stealth marketing efforts. Read More »

America’s Prisons: The Worst National Disgrace

Anthony Gregory | The Independent Institute | October 8, 2013

The U.S. correctional system is the worst of America’s domestic disgraces. More people languish behind bars in the United States than in any other country, except perhaps China if we factor in the unknown numbers in labor camps. [...] Read More »

Apple Tightens Acceptance Of Drug Guides For App Store

Greg Slabodkin | FierceMobileHealthcare | June 10, 2013

As part of stricter enforcement of developer policies for its App Store, Apple has been rejecting medical and health apps that provide information about prescription and over-the-counter medications, according to a recent article in CiteWorld. Read More »

Bad Pharma: Account Of The Bottomless Corruption Of The Pharma Industry Is A Stirring Call To Arms

Cory Doctorow | Boing Boing | November 6, 2012

I mentioned in September that Ben "Bad Science" Goldacre had a new book out, Bad Pharma: How drug companies mislead doctors and harm patients. I was sure at the time that this would be the usual excellent Goldacre fare -- lucid, thorough, and important. Now that I'm back from my own book tour, I've had a chance to read it and I'm pleased (or rather, furious -- more on this later) to report that this really is the usual, excellent Goldacre stuff. Read More »

Before The Prescription, Ask About Your Doctor's Finances

Leana Wen | Capital Public Radio | December 16, 2013

At the dawn of managed care, worried patients wanted to know whether their doctors were getting paid more to do less. Now, as many doctors' salaries depend on how many procedures they perform, patients want to know whether their doctors are paid more to do more. Read More »

Chaotic Drug Distribution Threatens Nigeria’s Health Sector

Staff Writer | BusinessDay | August 23, 2013

As counterfeit medicines continue to impact negatively on consumers, exposing them to dangerous and ineffective medical products, industry experts have expressed concern over the chaotic drug distribution system and sale of drugs in the open market, which is eroding the confidence of Nigeria’s pharmaceutical sector and threatening the health sector. Read More »

CredibleMeds® Announces Open-Source Drug Safety Resource

Press Release | AZCERT, CredibleMeds | October 23, 2013

QTdrugs List and Clinical Decision Support System Identifies Patients at Risk for Sudden Death; Adverse Drug Event Causality Analysis (ADECA™) Technology Generates QTdrugs List to Save Lives Read More »

Dazed And Confused: Drugs In Drinking Water

David Bard | The Allegiant | February 16, 2013

Drugs in Drinking Water: There is an unhealthy cocktail of drugs in your drinking water. With each sip, you self-medicate with anti-anxiety and even psychotropic drugs. Read More »

Doctors Denounce Cancer Drug Prices Of $100,000 A Year

Andrew Pollack | New York Times | April 25, 2013

With the cost of some lifesaving cancer drugs exceeding $100,000 a year, more than 100 influential cancer specialists from around the world have taken the unusual step of banding together in hopes of persuading some leading pharmaceutical companies to bring prices down. Read More »

Dollars For Docs Mints A Millionaire

Tracy Weber and Charles Ornstein | ProPublica | March 11, 2013

Dr. Jon W. Draud, the medical director of psychiatric and addiction medicine at two Tennessee hospitals, pursues some eclectic passions. He’s bred sleek Basenji hunting dogs for show. And last summer, the Tennessee State Museum featured “African Art: The Collection of Jon Draud.” Read More »

Drug Giant Glaxo Pleads Guilty, Fined $3B for Drug Marketing

Staff Writer | USA Today | July 2, 2012

Drug giant GlaxoSmithKline will plead guilty and pay $3 billion to resolve federal criminal and civil inquiries arising from the company's illegal promotion of some of its products, its failure to report safety data and alleged false price reporting, the Justice Department announced Monday. Read More »

e-Health Project In Malaysia To Monitor Medical Drug Preservation With Waspmote

Alberto Bielsa | Libelium | January 20, 2012

Medical drugs are very expensive, in special vaccines and others that need to be stored at a specific temperature. Therefore, real-time monitoring is vital to control whether the cold chain has been broken or not. Wireless sensor networks (WSN) are capable of getting temperature, humidity or luminosity measurements and transmit the data to a remote server periodically. In this way, real-time conditions can be monitored in order to know when a problem in a freezer or a refrigerator happens, avoiding critical situations and saving a huge amount of money.

Read More »

EU Agency Lifts Lid on Drug Data Secrets

Ben Hirschler | Reuters | July 15, 2012

Europe's medicines regulator, criticised in the past for excessive secrecy, is opening its data vaults to systematic scrutiny in a move that will let independent researchers trawl through millions of pages of clinical trial information. Read More »

Expensive Prescription Drugs: A Few Resources For Those In Need

Jeanne Pinder | Clear Health Costs | June 3, 2013

We’ve all heard about astonishingly expensive  drugs, and about drug company resources for helping people afford them. Read More »

FDA Clears IND For First Clinical Trial Protocol Developed Using Crowdsourcing

Press Release | Transparency Life Sciences (TLS) | December 18, 2012

Transparency Life Sciences, LLC (TLS), the world's first drug development company based on open innovation, today announced that its Investigational New Drug Application (IND) to assess lisinopril as an adjunctive therapy for multiple sclerosis (MS) has been cleared by the US Food and Drug Administration (FDA). Read More »